510 Shares in Chemed Corporation (NYSE:CHE) Bought by Silver Oak Securities Incorporated

Silver Oak Securities Incorporated bought a new stake in shares of Chemed Corporation (NYSE:CHE - Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 510 shares of the company's stock, valued at approximately $309,000.

Other hedge funds have also recently bought and sold shares of the company. Atala Financial Inc acquired a new position in shares of Chemed during the fourth quarter valued at about $29,000. CBIZ Investment Advisory Services LLC increased its stake in Chemed by 64.7% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after acquiring an additional 22 shares during the period. Whipplewood Advisors LLC raised its holdings in Chemed by 54.5% in the 1st quarter. Whipplewood Advisors LLC now owns 51 shares of the company's stock valued at $31,000 after acquiring an additional 18 shares in the last quarter. Tortoise Investment Management LLC lifted its position in shares of Chemed by 77.3% in the 4th quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after acquiring an additional 34 shares during the period. Finally, Brown Brothers Harriman & Co. grew its holdings in shares of Chemed by 633.3% during the 4th quarter. Brown Brothers Harriman & Co. now owns 88 shares of the company's stock worth $47,000 after purchasing an additional 76 shares in the last quarter. 95.85% of the stock is owned by institutional investors.

Chemed Trading Down 0.7%

CHE stock opened at $546.00 on Friday. Chemed Corporation has a 1-year low of $512.12 and a 1-year high of $623.61. The business's 50 day moving average is $568.51 and its 200-day moving average is $564.94. The firm has a market cap of $7.99 billion, a P/E ratio of 26.60, a P/E/G ratio of 2.27 and a beta of 0.54.

Chemed (NYSE:CHE - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. Chemed had a return on equity of 27.58% and a net margin of 12.40%. The business had revenue of $646.94 million for the quarter, compared to analyst estimates of $641.78 million. During the same quarter in the previous year, the firm earned $5.20 EPS. Chemed's quarterly revenue was up 9.8% on a year-over-year basis. Sell-side analysts forecast that Chemed Corporation will post 21.43 EPS for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 17th. Shareholders of record on Thursday, May 29th were given a $0.50 dividend. The ex-dividend date of this dividend was Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a yield of 0.37%. Chemed's dividend payout ratio (DPR) is presently 9.74%.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on CHE. Wall Street Zen raised Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank Of Canada increased their price objective on shares of Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th.

Insiders Place Their Bets

In other Chemed news, EVP Spencer S. Lee sold 1,500 shares of the business's stock in a transaction on Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the transaction, the executive vice president now owns 14,627 shares of the company's stock, valued at approximately $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Kevin J. Mcnamara sold 1,000 shares of the firm's stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the sale, the chief executive officer now owns 101,679 shares of the company's stock, valued at approximately $62,566,139.07. This trade represents a 0.97% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 5,500 shares of company stock valued at $3,213,780. 3.29% of the stock is currently owned by insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.